128,057
Views
65
CrossRef citations to date
0
Altmetric
Research Article

Evaluation of a COVID-19 IgM and IgG rapid test; an efficient tool for assessment of past exposure to SARS-CoV-2

ORCID Icon, , ORCID Icon, ORCID Icon, , , ORCID Icon, ORCID Icon & ORCID Icon show all
Article: 1754538 | Received 06 Apr 2020, Accepted 07 Apr 2020, Published online: 14 Apr 2020

References

  • Guarner J. Three emerging coronaviruses in two decadesthe story of SARS, MERS, and Now COVID-19. Am J Clin Pathol. 2020 Mar 9;153(4):420–5.
  • De Wit E , Van Doremalen N , Falzarano D , et al. SARS and MERS: recent insights into emerging coronaviruses [Internet]. Nature Reviews Microbiology Nature Publishing Group, London, UK; Aug 1 2016;523–534. Available from: www.nature.com/nrmicro
  • Hilgenfeld R , Peiris M. From SARS to MERS: 10 years of research on highly pathogenic human coronaviruses. Antiviral Res. 2013;100:286–295. [ Elsevier].
  • Wang D , Hu B , Hu C , et al. Clinical Characteristics of 138 hospitalized patients with 2019 novel coronavirus-infected pneumonia in Wuhan, China. J Am Med Assoc. 2020;323(11):1061. .
  • Huang C , Wang Y , Li X , et al. Clinical features of patients infected with 2019 novel coronavirus in Wuhan, China. Lancet. 2020 Feb 15;395(10223):497–506.
  • Wu Z , McGoogan JM . Characteristics of and important lessons from the coronavirus disease 2019 (COVID-19) outbreak in China: summary of a report of 72314 cases from the chinese center for disease control and prevention. J Am Med Assoc. 2020;323(13):1239.
  • Li Q , Guan X , Wu P , et al. Early transmission dynamics in Wuhan, China, of novel coronavirus–infected pneumonia. N Engl J Med. 2020 Jan 29;382(13):1199–1207.
  • Wu X , Cai Y , Huang X , et al. Co-infection with SARS-CoV-2 and influenza A virus in patient with pneumonia, China. Emerg Infect Dis. 2020 Jun;26(6). doi:10.3201/eid2606.200299.
  • Worldometer . Worldometer, Coronavirus [Internet]. 2020 [cited 2020 Apr 4 ]. Available from: https://www.worldometers.info/coronavirus/
  • European Centre for Disease Prevention and Control (ECDC) . Novel coronavirus disease 2019 (COVID-19) pandemic: increased transmission in the EU/EEA and the UK – sixth update [Internet]. Stockholm, Sweden; 2020. Available from: https://www.ecdc.europa.eu/sites/default/files/documents/RRA-sixth-update-Outbreak-of-novel-coronavirus-disease-2019-COVID-19.pdf
  • Li Z , Yi Y , Luo X , et al. Development and clinical application of a rapid IgM‐IgG combined antibody test for SARS‐CoV‐2 infection diagnosis. J Med Virol [Internet]. 2020 Feb 27. cited 2020 Apr 4 ;jmv:25727. Available from:: 10.1002/jmv.25727
  • Zhang J , Liu J , Li N , et al. Serological detection of 2019-nCoV respond to the epidemic: A useful complement to nucleic acid testing. medRxiv. 2020;10:20030916.
  • Gunther N , Hoffmann GW . Qualitative dynamics of a network model of regulation of the immune system: A rationale for the IgM to IgG switch. J Theor Biol. 1982 Feb 21;94(4):815–855.
  • Li G , Chen X , Xu A . Profile of specific antibodies to the SARS-associated coronavirus. N Engl J Med. 2003;349:508–509.
  • Hsueh PR , Huang LM , Chen PJ , et al. Chronological evolution of IgM, IgA, IgG and neutralisation antibodies after infection with SARS-associated coronavirus. Clin Microbiol Infect. 2004 Dec 1;10(12):1062–1066.
  • Wan WY , Lim SH , Seng EH . Cross-reaction of sera from COVID-19 patients with SARS-CoV assays. medRxiv [Internet]. 2020 Mar 23. cited 2020 Apr 1 ;20034454. Available from: 10.1101/2020.03.17.20034454v1
  • Paules CI , Marston HD , Fauci AS . Coronavirus infections-more than just the common cold. J Am Med Assoc. 2020;323:707–708.
  • Hofmann H , Pyrc K , Van Der Hoek L , et al. Human coronavirus NL63 employs the severe acute respiratory syndrome coronavirus receptor for cellular entry. Proc Natl Acad Sci U S A. 2005 May 31;102(22):7988–7993.
  • Bende M , Barrow I , Heptonstall J , et al. Changes in human nasal mucosa during experimental coronavirus common colds. Acta Otolaryngol. 1989;107(3–4):262–269. .
  • Zhao R , Li M , Song H , et al. Serological diagnostic kit of SARS-CoV-2 antibodies using CHO-expressed full-length SARS-CoV-2 S1 proteins. medRxiv. 2020;27:20042184.